A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2)

NCT03607422 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

912

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Placebo for Upadacitinib
DRUG: Upadacitinib

Sponsor

AbbVie